{"type":"trials","record":{"id":42085,"source_id":"clinicaltrials-gov","external_id":"NCT06076720","title":"Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision","brief_summary":"Glaucoma, age-related macular degeneration (AMD), retinitis pigmentosa, RP, diabetic retinopathy (DR) are the most common blinding eye diseases in the world. Vision and visual field are often severely impaired, quality of life is reduced, and personal and family burdens are heavy. This kind of low vision people, can use visual AIDS and other instruments for visual rehabilitation training, maximize the function of residual vision, improve the quality of life. Beyes, HOLA, Acesight and OXSIGHT are among the latest eyeglasses devices that are expected to improve the quality of life for people with low vision. This research group intends to recruit advanced patients with primary glaucoma, AMD, RP, DR and other common blinding eye diseases who visited Zhongshan Ophthalmology Center of Sun Yat-sen University from June 2021 to December 2022 to study the changes of visual function and quality of life after wearing this new type of head-worn visual aids, and analyze relevant factors combined with clinical data. To evaluate the effect and influencing factors of the new head-mounted visual AIDS on patients, and provide theoretical basis for subsequent clinical research.","overall_status":"Unknown","phases":[],"study_type":"INTERVENTIONAL","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","enrollment":50,"countries":["China"],"start_date":"2023-10-10","completion_date":"2024-10-10","last_update_date":"2023-10-11","source_url":"https://clinicaltrials.gov/study/NCT06076720","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:25:30.378222+00:00","last_seen_at":"2026-09-25T06:20:47.789+00:00","metadata":{"sex":"ALL","acronym":null,"age_range":"10 Years to 80 Years","comparator":null,"organization":"Zhongshan Ophthalmic Center, Sun Yat-sen University","interventions":["New head-mounted visual aids"],"registry_source":"ClinicalTrials.gov","outcome_measures":["Comparison of changes in the Glaucoma Visual Functioning Questionnaire-40 (GVFQ-40) scores at different time points — 8…","Comparison of changes in the National Eye Institute-Visual Function Questionnaire-25 (NEI VFQ-25) scores at different t…","Comparison of changes in the Low Vision Quality-of-Life Questionnaire (LVQOL) scores at different time points — 8 weeks…","Comparison of changes in visual acuity at different time points — 8 weeks after intervention","Comparison of changes in contrast sensitivity at different time points — 8 weeks after intervention","Comparison of changes in kinetic visual field at different time points — 8 weeks after intervention","Comparison of changes in functional magnetic resonance imaging (MRI) at different time points — 6 months after interven…","Comparison of changes in mobility test at different time points — 8 weeks after intervention","Comparison of changes in visual scanning test at different time points — 8 weeks after intervention"],"design_description":"NA · SINGLE GROUP · TREATMENT · NONE","source_has_results":false},"controlled_terms":["Glaucoma","Age-related Macular Degeneration","Retinitis Pigmentosa","Diabetic Retinopathy","New head-mounted visual aids"],"relevance_confidence":100,"source_quality_score":100,"freshness_score":65,"publication_state":"published","match_explanation":"Abstract contains controlled term: age-related macular degeneration.","quality_checked_at":"2026-09-25T06:20:59.355028+00:00","duplicate_cluster_key":"id:nct06076720","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2023-10-10 to 2024-10-10","comparator":null,"confidence":"structured-source","population":"ALL · 10 Years to 80 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:20:47.918Z","intervention":["New head-mounted visual aids"],"participants":50,"study_design":"NA · SINGLE GROUP · TREATMENT · NONE","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Comparison of changes in the Glaucoma Visual Functioning Questionnaire-40 (GVFQ-40) scores at different time points — 8…","Comparison of changes in the National Eye Institute-Visual Function Questionnaire-25 (NEI VFQ-25) scores at different t…","Comparison of changes in the Low Vision Quality-of-Life Questionnaire (LVQOL) scores at different time points — 8 weeks…","Comparison of changes in visual acuity at different time points — 8 weeks after intervention","Comparison of changes in contrast sensitivity at different time points — 8 weeks after intervention","Comparison of changes in kinetic visual field at different time points — 8 weeks after intervention","Comparison of changes in functional magnetic resonance imaging (MRI) at different time points — 6 months after interven…","Comparison of changes in mobility test at different time points — 8 weeks after intervention","Comparison of changes in visual scanning test at different time points — 8 weeks after intervention"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"vision-aging","is_published":true,"match_reasons":["Abstract contains controlled term: age-related macular degeneration.","Source terminology contains: age-related macular degeneration.","Abstract supplies longevity context: age-related.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["abstract","controlled terminology","abstract context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Vision ageing","slug":"vision-aging"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/42085","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}